BioCentury
ARTICLE | Financial News

Fate Therapeutics completes follow-on

May 25, 2015 7:00 AM UTC

Fate Therapeutics Inc. (NASDAQ:FATE), San Diego, Calif. Business: Gene/Cell therapy, Cancer, Musculoskeletal Date completed: 2015-05-20 Type: Follow-on Raised: $30 million Shares: 6 million Price: $5 ...